Norfloxacin and trimethoprim–sulfamethoxazole therapy have similar efficacy in prevention of spontaneous bacterial peritonitis

Abstract

Our findings suggest N and TS have similar efficacy in preventing SBP. This has significant implications for both the cost of SBP prophylaxis and the prevalence of fluoroquinolone resistance in patients with cirrhosis.